Patents by Inventor Melissa Vos

Melissa Vos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100072
    Abstract: The present disclosure relates to safe and effective subcutaneously administered treatments for advanced Parkinson's disease.
    Type: Application
    Filed: October 27, 2022
    Publication date: March 28, 2024
    Inventors: Maurizio F. Facheris, Michael Gold, Weining Z. Robieson, Melissa Vos, Amy M. Spiegel, Nahome Tezera Fisseha, Janet A. Benesh, George Liossis, Kumar Budur
  • Patent number: 11202795
    Abstract: This application relates to the field of neurodegenerative diseases, more particularly to the field of Parkinson's disease. In particular, the disclosure describes that inhibitors reducing FAS activity can be used for treatment of Parkinson's disease, in particular, the treatment of patients suffering from Parkinson's disease having loss of function mutations in PINK1 or PARKIN genes.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: December 21, 2021
    Assignees: VIB VZW, Katholieke Universiteit Leuven, KU Leuven R&E
    Inventors: Patrik Verstreken, Vanessa Morais Epifânio, Melissa Vos
  • Publication number: 20170319610
    Abstract: This application relates to the field of neurodegenerative diseases, more particularly to the field of Parkinson's disease. In particular, the disclosure describes that inhibitors reducing FAS activity can be used for treatment of Parkinson's disease, in particular, the treatment of patients suffering from Parkinson's disease having loss of function mutations in PINK1 or PARKIN genes.
    Type: Application
    Filed: November 20, 2015
    Publication date: November 9, 2017
    Inventors: Patrik Verstreken, Vanessa Morais Epifânio, Melissa Vos